Coronary endothelial dysfunction and impaired microcirculation response to atrial natriuretic peptide in hyperinsulinemia

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 13, Issue 1, 2008, Pages 58-63

  Ashikaga, Takashi ^a   Nishizaki, Mitsuhiro ^a   Fujii, Hiroyuki ^a   Ihara, Kensuke ^a   Niki, Saori ^a   Murai, Tadashi ^a   Maeda, Shingo ^a   Yamawake, Noriyoshi ^a   Kishi, Yukio ^b   Isobe, Mitsuaki ^c  

^a Yokohama Minami Kyosai Hospital   (Japan)

^b TOKYO KYOSAI HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide; Endothelial dysfunction; Hyperinsulinemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; ISOSORBIDE DINITRATE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY FLOW RESERVE; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPERINSULINEMIA; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; VASOCONSTRICTION;

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; AGED; ATRIAL NATRIURETIC FACTOR; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; ISOSORBIDE DINITRATE; MALE; MICROCIRCULATION; MIDDLE AGED; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 39049110097     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248407313397     Document Type: Article

References (27)

1. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol. 1996 ; 7 (4). 217-226.
2. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998 ; 97 (10). 996-1001.
3. Pyorala M., Miettinen H., Laasko M., Pyorala K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: 22-year follow-up results of the Helsinki Policeman Study. Circulation. 1998 ; 98 (5). 398-404.
4. Despres JP, Lamarche B., Maurieqe P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996 ; 334 (15). 952-957.
5. Zavaroni I., Borona E., Pagliara M., et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989 ; 320 (11). 702-706.
6. Zeiher AM, Drexler H., Wollschlager H., Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991 ; 83 (2). 391-401.
7. Cauhan A., Foote J., Petch MC, Schofield PM Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol. 1994 ; 23 (2). 364-368.
8. Dagres N., Saller B., Haude M., et al. Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects. Clin Endocrinol (Oxf). 2004 ; 61 (6). 724-731.
9. Kishi Y., Ashikaga T., Watanabe R., Numano F. Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells. J Cardiovasc Pharmacol. 1994 ; 24 (3). 351-357.
10. Rosenthal AD, Moran M., Herrmann HC Coronary hemodynamic effects of atrial natriuretic peptide in humans. J Am Coll Cardiol. 1990 ; 16 (5). 1107-1013.
11. Sonoda S., Takeuchi M., Nakashima Y., Kuroiwa A. Safety and optimal dose of intracoronary adenosine 5'triphosphate for the measurement of coronary flow reserve. Am Heart J. 1998 ; 135 (4). 621-627.
12. Ashikaga T., Nishizaki M., Fujii H., et al. Examination of microcirculation damage in smokers versus nonsmokers with vasospastic angina pectoris. Am J Cardiol. 2007 ; 100 (6). 962-964.
13. Tritos NA, Mantzoros CS Syndromes of severe insulin resistance. J Clin Endocrinol Metab. 1998 ; 83 (9). 3025-3030.
14. Rönnemaa T., Knip M., Lautala P., et al. Serum insulin and other cardiovascular risk indicators in children and adolescent and young adults. Ann Med. 1991 ; 23 (1). 67-72.
15. Schächinger V., Zeiher AM Quantitative assessment of coronary vasoreactivity in humans in vivo: importance of baseline vasomotor tone in atherosclerosis. Circulation. 1995 ; 92 (8). 2087-2094.
16. Shimabukuro M., Shinzato T., Higa S., et al. Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina. J Am Coll Cardiol. 1995 ; 25 (2). 356-361.
17. Hirashima O., Kawano H., Motoyama T., et al. Improvement of endothelial function and insulin sensitivity with vitamin C in patients with coronary spastic angina: possible role of reactive oxygen species. J Am Coll Cardiol. 2000 ; 35 (7). 1860-1866.
18. Shinozaki K., Hirayama A., Nishio Y., et al. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol. 2001 ; 38 (7). 1821-1828.
19. Kugiyama K., Motoyama T., Hirashima O., et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol. 1998 ; 32 (6). 103-109.
20. Steinberg HO, Chaker H., Leaming R., Johnson A., Bechtel G., Baron AD Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest. 1996 ; 97 (11). 2601-2610.
21. Mäkimattila S., Virkamäki A., Groop PH, et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent mellitus. Circulation. 1996 ; 94 (6). 1276-1282.
22. Chu A., Cobb FR Effects of atrial natriuretic peptide on proximal epicardial coronary arteries and coronary blood flow in conscious dogs. Circ Res. 1987 ; 61 (4). 485-491.
23. Chu A., Morris K., Kuehl WD, Cusma J., Navetta F., Cobb FR Effects of atrial natriuretic peptide on the coronary arterial vasculature in humans. Circulation. 1989 ; 80 (6). 1627-1635.
24. Egashira K., Inou T., Imaizumi T., Tomoike H., Takeshita A. Effects of synthetic atrial natriuretic peptide on the human coronary circulation in subjects with normal coronary arteries. Jpn Circ J. 1991 ; 55 (11). 1051-1056.
25. Itoh H., Pratt RE, Dzau VJ Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990 ; 86 (5). 1690-1697.
26. Modan M., Halkin H., Almog S., et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985 ; 75 (3). 809-817.
27. Ferri C., Bellini C., Desideri G., et al. Salt-sensitivity is associated with a hyperinsulinaemic and hyperglycaemic response to atrial natriuretic peptide infusion in human essential hypertension. Diabetologia. 1994 ; 37 (3). 308-312.